Publication:
Pulse methylprednisolone therapy in Landau-Kleffner Syndrome

dc.contributor.authorARMAN, AYŞE
dc.contributor.authorsAykutBingol, C; Arman, A; Tokol, O; Afsar, N; Aktan, S
dc.date.accessioned2022-03-12T16:56:02Z
dc.date.accessioned2026-01-10T16:57:40Z
dc.date.available2022-03-12T16:56:02Z
dc.date.issued1996
dc.description.abstractLandau-Kleffner syndrome (LKS) is a subtype of acquired childhood aphasia associated with characteristic paroxysmal EEG recording of spikes and spike and wave complexes. The seizures, which start independently of the onset of aphasia, usually respond to antiepileptic drugs and have a good prognosis, but recovery of aphasia is variable. Steroid therapy has been recommended in recent years. We report an 8-year old girl with LKS who received intravenous high-dose methylprednisolone therapy without any side effect.
dc.identifier.doi10.1016/0896-6974(96)00026-6
dc.identifier.issn0896-6974
dc.identifier.urihttps://hdl.handle.net/11424/226642
dc.identifier.wosWOS:A1996VC49400007
dc.language.isoeng
dc.publisherBUTTERWORTH-HEINEMANN
dc.relation.ispartofJOURNAL OF EPILEPSY
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectLandau-Kleffner syndrome
dc.subjectmethylprednisolone
dc.subjectpulse steroid
dc.subjectCHILDREN
dc.subjectAPHASIA
dc.subjectEEG
dc.titlePulse methylprednisolone therapy in Landau-Kleffner Syndrome
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPage191
oaire.citation.issue3
oaire.citation.startPage189
oaire.citation.titleJOURNAL OF EPILEPSY
oaire.citation.volume9

Files